mek inhibitors for melanoma: new combination approved
Published 5 years ago • 236 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
2:10
combined treatment with braf and mek inhibitors in metastatic melanomas with braf mutations
-
9:24
anti-pd1 monotherapy or combination with ipi after braf/mek inhibitors in braf-mutant melanoma
-
4:07
understanding resistance to combined braf and mek inhibiton in melanoma and the significance of cdk4
-
1:33
dr. paul chapman on braf and mek inhibitor combination for advanced melanoma
-
1:02
dr. kudchadkar on combining brad and mek inhibitors to treat melanoma
-
1:34
study of vemurafenib combined with a mek inhibitor
-
4:56
combination fak and raf-mek inhibitors showing promise as a uveal melanoma treatment
-
0:52
dr. kudchadkar on combining braf and mek inhibitors to treat melanoma
-
2:10
using biomarkers to predict response to combination therapies in braf-mutant melanoma
-
1:19
dr. postow on braf and mek inhibitor combination studies in melanoma
-
8:47
braf/mek inhibitors in metastatic melanoma
-
8:24
management of side effects for braf/mek inhibitors for melanoma
-
4:17
combo braf mek inhibition best in braf mutant metastatic melanoma
-
1:09
rationale for mek/braf combinations in melanoma
-
10:42
what is new in melanoma?
-
6:31
dr. alex adjei explains mek inhibitors
-
4:15
vemurafenib in combination with the mek inhibitor, gdc-0973 in brafv600 mutation pos melanoma
-
10:08
perspectives on braf and mek inhibitor combinations in braf-mutant melanoma
-
5:17
dirk schadendorf, esmo 2018 – encorafenib plus binimetinib for braf-mutant metastatic melanoma